Business Context and Reporting Period
This Form 6-K, filed on August 11, 2025, by Moolec Science SA (a Cayman Islands entity following a June 2025 redomiciliation from Luxembourg), provides updated unaudited pro forma financial information. The filing reflects the closing of a Business Combination on June 16, 2025, involving Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC. Additionally, the report details a 10-to-1 reverse stock split effective May 14, 2025, and the deconsolidation of Bioceres Crop Solutions Corp. (BIOX) due to a loss of de facto control.
Key Financial Metrics and Liquidity
The filing does not provide specific consolidated revenue, profit, or cash flow figures for the combined entity in this text; it references exhibits for detailed pro forma statements. However, it discloses significant debt obligations and liquidity constraints:
- Debt Defaults: Bioceres S.A. defaulted on $36.4 million in financial debt due in June 2025. Bioceres LLC defaulted on $69.5 million in July 2025.
- Collateral Auction: A creditor conducted a public auction for 3,062,500 pledged BIOX shares related to the Bioceres LLC default.
- Liquidity Status: The Group currently lacks sufficient financial resources to meet obligations or fully implement its business plan.
- Debt Restructuring: Bioceres Crop Solutions Corp. amended its Secured Notes, extending maturity to August 31, 2027, and modifying leverage ratios, which triggered the loss of control and deconsolidation.
Material Changes Versus Prior Period
Significant structural and operational changes have occurred since the April 2025 pro forma filing:
- Deconsolidation: Bioceres Crop Solutions Corp. is no longer consolidated due to the loss of de facto control following the amendment of its Secured Notes and the replacement of board members by note holders.
- Capital Structure: A 10-to-1 reverse stock split was completed, adjusting all share data and per-share metrics.
- Corporate Jurisdiction: The company redomiciled from Luxembourg to the Cayman Islands.
- Financing Restrictions: The loss of control over Bioceres Crop Solutions Corp. has restricted or limited access to financing previously available to the Group.
Outlook, Risks, and Management Commentary
Going Concern Uncertainty: The filing explicitly states that the defaults and lack of resources raise a material uncertainty that casts significant doubt on the Group's ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty.
Management Plans:
- Establishment of a Restructuring Committee to address financial restructuring.
- Proposals to extend debt maturities and utilize operating cash inflows.
- Expectations that shareholders or investors will provide new financing lines.
Risks: There is no assurance that the restructuring will succeed, that new financing will be secured, or that future operations will be profitable. Without additional capital or successful restructuring, the Group cannot sustain operations.
Investor Verification Checklist
- Verify the status of the $36.4 million (Bioceres S.A.) and $69.5 million (Bioceres LLC) debt defaults and the outcome of the pledged share auction.
- Confirm the progress of the financial restructuring process and the establishment of new financing lines.
- Review the unaudited pro forma condensed combined financial information in Exhibit 99.1 for updated revenue and margin projections post-deconsolidation.
- Assess the impact of the deconsolidation of Bioceres Crop Solutions Corp. on the Group's overall asset base and revenue streams.
- Monitor the Group's ability to secure additional capital to address the stated going concern uncertainty.